Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
SURGERY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Nausea,	O
UTI	B-Urinary_tract_infection
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
HPI:	O
Ms.	O
___	O
is	O
a	O
___	O
year-old	O
woman	O
who	O
was	O
recently	O
discharged	O
after	O
a	O
completion	O
pancreatectomy	O
and	O
splenectomy	O
on	O
___	O
who	O
presents	O
5	O
days	O
after	O
diagnosis	O
of	O
UTI	B-Urinary_tract_infection
with	O
continued	O
elevated	O
blood	O
sugars,	O
nausea,	O
fatigue	O
and	O
weight	B-Weight_loss
loss.	B-Weight_loss
She	O
was	O
doing	O
well	O
after	O
returning	O
home	O
but	O
5	O
days	O
ago	O
began	O
to	O
develop	O
fatigue	O
and	O
uncontrolled	O
blood	O
sugars.	O
PCP	O
obtained	O
UA	O
which	O
was	O
positive	O
and	O
she	O
was	O
initiated	O
on	O
Macrobid	O
at	O
that	O
time.	O
However,	O
she	O
has	O
not	O
improved	O
in	O
terms	O
of	O
her	O
fatigue	O
and	O
nausea.	O
She	O
called	O
in	O
during	O
the	O
day	O
and	O
we	O
suggested	O
evaluation	O
at	O
nearby	O
urgent	O
care,	O
and	O
she	O
was	O
subsequently	O
transferred	O
to	O
___	O
for	O
further	O
evaluation.	O
On	O
arrival,	O
vitals	O
were	O
stable	O
and	O
she	O
is	O
in	O
no	O
acute	O
distress.	O
She	O
has	O
mild	O
nausea.	O
She	O
denies	O
changes	O
in	O
urinary	O
or	O
bowel	O
habits.	O
She	O
denies	O
chest	O
pain	O
or	O
shortness	O
of	O
breath,	O
and	O
denies	O
abdominal	O
pain.	O
Past	O
Medical	O
History:	O
Past	O
Medical	O
History:	O
1.	O
DCIS	O
of	O
the	O
left	O
breast,	O
diagnosed	O
in	O
___.	O
She	O
underwent	O
lumpectomy	O
with	O
multifocal	O
disease	O
found,	O
with	O
a	O
subsequent	O
completion	O
mastectomy	O
and	O
autologous	O
reconstruction.	O
She	O
received	O
no	O
adjuvant	O
therapy	O
or	O
hormone	O
therapy.	O
2.	O
GERD.	O
3.	O
Migraines.	O
4.	O
Diverticulitis.	O
5.	O
Pancreatic	O
adenocarcinoma.	O
PAST	O
SURGICAL	O
HISTORY:	O
-	O
___	O
-	O
radical	O
pancreaticoduodenectomy	O
(including	O
pancreatic	O
neck	O
and	O
proximal	O
body)	O
with	O
en	O
bloc	O
resection	O
of	O
SMV/splenic	O
vein/portal	O
vein	O
with	O
reconstruction	O
using	O
left	O
internal	O
jugular	O
vein	O
-	O
___	O
-	O
completion	O
pancreatectomy	O
and	O
splenectomy	O
-	O
left	O
mastectomy,	O
reconstruction	O
with	O
TRAM	O
flap	O
-	O
colonoscopy	O
-	O
colporrhaphy	O
-	O
exploratory	O
laparoscopy	O
-	O
portacath	O
placement	O
Social	O
History:	O
___	O
Family	O
History:	O
Family	O
History:	O
Significant	O
for	O
a	O
cousin	O
with	O
breast	O
cancer,	O
otherwise	O
no	O
history	O
of	O
malignancy.	O
Physical	O
Exam:	O
Physical	O
Exam:	O
Temp:	O
98.3	O
PO	O
BP:	O
127/79	O
L	O
Lying	O
HR:	O
68	O
RR:	O
18	O
O2	O
sat:	O
99%	O
O2	O
delivery:	O
RA	O
GEN:	O
A&O	B-Delirium
x	B-Delirium
3,	B-Delirium
NAD	O
HEENT:	O
no	O
scleral	O
icterus	O
CV:	O
RRR,	O
no	O
m/r/g	O
PULM:	O
CTAB	O
ABD:	O
Nontender,	O
non-distended.	O
Midline	O
incision	O
open	O
to	O
air	O
with	O
staples	O
and	O
c/d/I	O
EXTR:	O
Warm,	O
no	O
c/c/e	O
Pertinent	O
Results:	O
___	O
04:32PM	O
BLOOD	O
WBC-10.8*	O
RBC-3.12*	O
Hgb-8.9*	O
Hct-27.9*	O
MCV-89	O
MCH-28.5	O
MCHC-31.9*	O
RDW-18.9*	O
RDWSD-61.9*	O
Plt	O
___	O
___	O
04:32PM	O
BLOOD	O
Neuts-69.6	O
Lymphs-12.8*	O
Monos-13.3*	O
Eos-3.1	O
Baso-0.8	O
NRBC-0.2*	O
Im	O
___	O
AbsNeut-7.52*	O
AbsLymp-1.38	O
AbsMono-1.43*	O
AbsEos-0.33	O
AbsBaso-0.09*	O
___	O
04:32PM	O
BLOOD	O
Glucose-245*	O
UreaN-13	O
Creat-0.5	O
Na-132*	O
K-4.9	O
Cl-93*	O
HCO3-24	O
AnGap-15	O
___	O
04:32PM	O
BLOOD	O
ALT-8	O
AST-13	O
AlkPhos-105	O
TotBili-0.4	O
___	O
04:32PM	O
BLOOD	O
Albumin-3.9	O
Calcium-9.4	O
Phos-3.6	O
Mg-2.0	O
CT	O
abd	O
pelvis,	O
___	O
IMPRESSION:	O
1.	O
Irregular-shaped	O
fluid	O
collection	O
tracking	O
along	O
the	O
medial	O
edge	O
of	O
the	O
liver,	O
surrounding	O
the	O
intrahepatic	O
IVC,	O
and	O
extending	O
into	O
the	O
portal	O
hepatis.	O
The	O
fluid	O
collection	O
measures	O
approximately	O
5.8	O
x	O
4.2	O
in	O
the	O
superior	O
component	O
and	O
5.3	O
x	O
2.0	O
cm	O
in	O
the	O
inferior	O
component	O
surrounding	O
intrahepatic	O
IVC	O
and	O
spanning	O
approximately	O
9.0	O
cm	O
craniocaudally.	O
This	O
likely	O
reflects	O
a	O
postoperative	O
seroma,	O
but	O
please	O
note	O
that	O
infection	O
of	O
this	O
fluid	O
collection	O
cannot	O
be	O
excluded	O
on	O
the	O
basis	O
of	O
this	O
imaging	O
exam.	O
2.	O
Postoperative	O
changes	O
in	O
the	O
central	O
abdomen	O
post	O
pancreatectomy	O
and	O
splenectomy.	O
3.	O
New	O
mesenteric	O
lymphadenopathy	O
inferior	O
to	O
the	O
surgical	O
bed	O
which	O
may	O
be	O
reactive.	O
Continued	O
surveillance	O
is	O
advised.	O
4.	O
Pneumobilia	O
as	O
expected	O
from	O
hepaticojejunostomy.	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
presented	O
to	O
ED	O
on	O
___	O
with	O
nausea	O
and	O
lethargy	O
and	O
dysuria.	O
Initial	O
CT	O
of	O
abdomen	O
and	O
pelvis	O
showed	O
a	O
seroma	O
but	O
it	O
was	O
consistent	O
with	O
expected	O
post-operative	O
changes.	O
Patient	O
was	O
admitted	O
to	O
our	O
service.	O
___	O
and	O
ID	O
were	O
consulted	O
to	O
help	O
with	O
adequate	O
management	O
of	O
her	O
UTI	B-Urinary_tract_infection
as	O
well	O
as	O
her	O
glucose	O
control.	O
___	O
recommended	O
to	O
increase	O
lantus	O
from	O
6	O
to	O
8;	O
and	O
increase	O
Humalog	O
base	O
dose	O
to	O
4	O
and	O
increase	O
by	O
1	O
unit	O
for	O
every	O
50	O
pts	O
above	O
150;	O
they	O
reviewed	O
it	O
with	O
pt	O
and	O
family	O
and	O
scheduled	O
f/u	O
at	O
___.	O
Patient	O
was	O
on	O
MAcrobid	O
for	O
5	O
days	O
with	O
no	O
resolution	O
of	O
dysuria,	O
ID	O
recommended	O
switching	O
to	O
po	O
ciproflox	O
ABx	O
for	O
10	O
days.	O
#NEURO:	O
The	O
patient	O
was	O
alert	O
and	O
oriented	B-Delirium
throughout	O
hospitalization;	O
pain	O
was	O
very	O
well	O
controlled.	O
#CV:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
cardiovascular	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
#PULMONARY:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
pulmonary	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Good	O
pulmonary	O
toilet,	O
ambulation	O
and	O
incentive	O
spirometry	O
were	O
encouraged	O
throughout	O
hospitalization.	O
#GI/GU/FEN:	O
The	O
patient	O
was	O
tolerating	O
a	O
regular	O
diet.	O
Patient	O
urine	O
output	O
was	O
appropriate.	O
#ID:	O
The	O
patient's	O
fever	O
curves	O
were	O
closely	O
watched	O
for	O
signs	O
of	O
infection,	O
of	O
which	O
there	O
were	O
none.	O
#HEME:	O
Patient	O
received	O
BID	O
SQH	O
for	O
DVT	O
prophylaxis,	O
in	O
addition	O
to	O
encouraging	O
early	O
ambulation	O
and	O
Venodyne	O
compression	O
devices.	O
At	O
the	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
doing	O
well,	O
afebrile	O
with	O
stable	O
vital	O
signs.	O
The	O
patient	O
was	O
tolerating	O
diet	O
as	O
above	O
per	O
oral,	O
ambulating,	O
voiding,	O
and	O
pain	O
was	O
well	O
controlled.	O
The	O
patient	O
was	O
discharged	O
home	O
on	O
Antibiotics.	O
The	O
patient	O
received	O
discharge	O
teaching	O
and	O
follow-up	O
instructions	O
with	O
understanding	O
verbalized	O
and	O
agreement	O
with	O
the	O
discharge	O
plan.	O
Medications	O
on	O
Admission:	O
insulin	O
glargine	O
[Basaglar	O
KwikPen	O
U-100	O
Insulin],	O
lipase-protease-amylase	O
[Creon],	O
insulin	O
aspart	O
U-100	O
[Novolog	O
Flexpen	O
U-100	O
Insulin],	O
blood	O
sugar	O
diagnostic	O
[OneTouch	O
Verio],	O
acetaminophen,	O
aspirin,	O
blood-glucose	O
meter,	O
blood-glucose	O
meter,	O
enoxaparin,	O
lancets,	O
omeprazole,	O
ondansetron,	O
pen	O
needle,	O
diabetic,	O
prochlorperazine	O
maleate,	O
ranitidine	O
HCl,	O
Lovenox	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild/Fever	O
2.	O
Ciprofloxacin	O
HCl	O
500	O
mg	O
PO	O
Q12H	O
RX	O
*ciprofloxacin	O
HCl	O
500	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
twelve	O
(12)	O
hours	O
Disp	O
#*18	O
Tablet	O
Refills:*0	O
3.	O
Creon	O
12	O
3	O
CAP	O
PO	O
TID	O
W/MEALS	O
4.	O
Enoxaparin	O
Sodium	O
40	O
mg	O
SC	O
DAILY	O
Start:	O
___,	O
First	O
Dose:	O
Next	O
Routine	O
Administration	O
Time	O
5.	O
Glargine	O
8	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
UTI,	B-Urinary_tract_infection
hyperglycemia	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
surgery	O
service	O
at	O
___	O
for	O
blood	O
glucose	O
management	O
and	O
treatment	O
of	O
your	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
You	O
have	O
done	O
well	O
in	O
the	O
post	O
operative	O
period	O
and	O
are	O
now	O
safe	O
to	O
return	O
home	O
to	O
complete	O
your	O
recovery	O
with	O
the	O
following	O
instructions:	O
.	O
Please	O
call	O
Dr.	O
___	O
office	O
at	O
___	O
or	O
Office	O
RNs	O
at	O
___	O
if	O
you	O
have	O
any	O
questions	O
or	O
concerns.	O
.	O
Please	O
continue	O
with	O
___	O
recommendations,	O
follow	O
up	O
with	O
___	O
as	O
scheduled.	O
.	O
General	O
Discharge	O
Instructions:	O
Please	O
resume	O
all	O
regular	O
home	O
medications	O
,	O
unless	O
specifically	O
advised	O
not	O
to	O
take	O
a	O
particular	O
medication.	O
Also,	O
please	O
take	O
any	O
new	O
medications	O
as	O
prescribed.	O
Please	O
get	O
plenty	O
of	O
rest,	O
continue	O
to	O
ambulate	O
several	O
times	O
per	O
day,	O
and	O
drink	O
adequate	O
amounts	O
of	O
fluids.	O
Avoid	O
lifting	O
weights	O
greater	O
than	O
___	O
lbs	O
until	O
you	O
follow-up	O
with	O
your	O
surgeon,	O
who	O
will	O
instruct	O
you	O
further	O
regarding	O
activity	O
restrictions.	O
Avoid	O
driving	O
or	O
operating	O
heavy	O
machinery	O
while	O
taking	O
pain	O
medications.	O
Please	O
follow-up	O
with	O
your	O
surgeon	O
and	O
Primary	O
Care	O
Provider	O
(PCP)	O
as	O
advised.	O
.	O
Incision	O
Care:	O
*Please	O
call	O
your	O
doctor	O
or	O
nurse	O
practitioner	O
if	O
you	O
have	O
increased	O
pain,	O
swelling,	O
redness,	O
or	O
drainage	O
from	O
the	O
incision	O
site.	O
*Avoid	O
swimming	O
and	O
baths	O
until	O
your	O
follow-up	O
appointment.	O
*You	O
may	O
shower,	O
and	O
wash	O
surgical	O
incisions	O
with	O
a	O
mild	O
soap	O
and	O
warm	O
water.	O
Gently	O
pat	O
the	O
area	O
dry.	O
*If	O
you	O
have	O
staples,	O
they	O
will	O
be	O
removed	O
at	O
your	O
follow-up	O
appointment.	O
Followup	O
Instructions:	O
___	O

